Cardiovascular Surgical Devices: Technologies and Global Markets - a new market research report on companiesandmarkets.com
PR-Inside.com: 2014-03-24 01:19:04
The global cardiovascular surgical devices market was valued at $29.7 billion in 2012 and is expected to reach nearly $31.7 billion in 2013. The market is forecast to grow to nearly $47.2 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 8.3% from 2013 to 2018.Cardiovascular disease is the leading cause of death for both men and women in the United States, as well as in many other countries around the world. The American Heart Association estimates that 83.6 million American adults, or more than one in three, have one or more types of cardiovascular disease. Indeed, more Americans die of heart disease than of the combination of all cancers and AIDS.In 2010, over 7.5 million inpatient cardiovascular operations and procedures were performed in the United States alone. During that year, the total inpatient hospital cost for cardiovascular disease was estimated to be $71.2 billion, about one quarter to the total cost of U.S. inpatient hospital care. The American Heart Association further estimates that, by 2030, the total direct medical costs associated with cardiovascular disease in the U.S. alone will increase from an estimated $312.6 million in 2009 to almost $1.5 trillion (in 2010 dollars).Although incidence rates of cardiovascular disease in many European and other developed nations parallel those of the United States, many developing nations actually have much higher rates of cardiovascular disease. The World Health Organization estimates that 60% of all cardiovascular disease occurs in less developed countries. Recent increase in incidence of cardiovascular disease has been fueled by higher obesity rates in less developed countries; for example, WHO estimates that there are 70 million overweight people in China alone. The global economic burden of coronary heart disease is projected to rise from an estimated 47 million disability adjusted life years in 1990 to an estimated 82 million disability adjusted life years by 2020. This increase will be most acutely felt in nations such as Egypt, India and the republics of the former Soviet Union.As new medical technologies become more widespread in these areas, the demand for cost-effective cardiovascular disease treatment options will experience strong growth. Medical advances, aging populations, increasing rates of obesity, and poor nutrition will drive significant growth in this market for the foreseeable future.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.